RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
about
RASSF tumor suppressor gene family: biological functions and regulationEpigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen studyThe identification of specific methylation patterns across different cancersEPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.DNA methylation in endometriosis (Review).Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer.Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Differential gene hypermethylation in genital lichen sclerosus and cancer: a comparative study.Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
P2860
Q26866080-FF0374F5-C853-447B-9E9B-C842958D59B8Q28390359-42975075-6DEB-41A4-BBAD-1BC87F96521FQ35182046-FA19088E-4285-4DA3-BA9F-0E84ADE647E5Q35238478-A73BBB3C-CF7B-4DE5-B2EA-2641A4DB6F7DQ36414347-ADF2565C-F7AB-4A3C-BB60-468DAB60E2EFQ36722241-134AA569-B42F-4324-AE12-6785478A95A6Q38470611-2BE952CE-CA00-4599-9599-24D93DFEB3F1Q38756890-6ACCB47D-2975-4CF6-9349-EA8DF069E075Q39583823-05C9ABA9-464E-4501-846C-7B8A0F933665Q41083940-2C9C0B8B-8962-486D-84B2-A1A6775E9241Q41202043-E719F71F-A433-423E-935E-31B95B75B3A9Q42272615-BD1A9CC0-2A7C-4D04-A3CA-9A312EEE5054Q53118366-D84B45F5-6011-4BC5-8D07-D9F4B34A91A1Q53315728-579DF237-0C94-4E68-A073-DFDF30EBEBEB
P2860
RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@en
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@nl
type
label
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@en
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@nl
prefLabel
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@en
RASSF2 hypermethylation is pre ...... l in squamous cervical cancer.
@nl
P2093
P2860
P50
P1433
P1476
RASSF2 hypermethylation is pre ...... al in squamous cervical cancer
@en
P2093
Amaya Ojer
Laura Blanco-Fernandez
María Berdasco
Natalia Torrea
Noemí Pérez-Janices
Rosa Guarch
Sergio Maria-Ruiz
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.32
P577
2013-03-29T00:00:00Z